Thursday, 19th October 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases 2017

Proudly Sponsored by 

• The INFECT-project; a multicentre prospective study on necrotizing soft tissue infections: from clinics to pathogenesis to intervention. - Anna Norrby-Teglund
• New insights into SLO and NADase as co-toxins. - Michael R Wessels
• Modulation of the immune response by encapsulated streptococci: elucidating the role of sialylated capsular polysaccharides - Mariela Segura
• Multivalent group A streptococcal vaccines: past, present, and future - James B Dale
• Role of zinc in group A streptococcal pathogenesis - Mark Walker

• Genome-wide CRISPR/Cas9 screening to identify alternative receptors for streptolysin O - Buket Baddal
• Efficacy of a non-M protein GAS vaccine in a primate model of pharyngitis and tonsillitis   - Tania Rivera Hernandez
• The economic and health burden of disease caused by group A streptococcus in Australia and New Zealand - Jeffrey W Cannon
• What can a million throat swabs tell us about the distribution of group A Streptococcus and acute rheumatic fever? - Jane Oliver
• The IgdE family of streptococcal Immunoglobulin degrading enzymes - Are you my host? - Christian Spoerry
• FasX is a virulence-regulating small regulatory RNA in the group A Streptococcus   - Jess Danger

• Decoding the serological typing genes of Group A Streptococci into an ecological framework - Debra Bessen
• Mathematical modelling of Group A streptococcal infection and transmission - Nic Geard
• Epidemiology of invasive Group A streptococcal disease in Alberta, Canada, 2007-2016. - Gregory J. Tyrrell
• The epidemiology of invasive and non-invasive group A streptococcus in Cape Town, South Africa: The AFROStrep Registry - Mark Engel
• The epidemiology of Streptococcus pyogenes infection among children in Blantyre. - Rizine R Mzikamanda
• Investigation of Group A streptococcus immune responses in an endemic setting with a particular focus on J8 - Patricia T Campbell

• Integration of Host and Bacterial Signals Leads to Production of Group A Streptococcal Bacteriocins Contributing to Niche Control. - Emanuel Hanski
• Group A Streptococcus is not the sole agent contributing to the pathogenesis of rheumatic heart disease - Natkunam Ketheesan
• Group A Streptococcal M protein activates the NLRP3 inflammasome and triggers programmed cell death in macrophages - Andrés Valderrama
• Using Human Organotypic Skin to Model Severe Streptococcal Infection - Mattias Svensson
• Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T cells - John K McCormick
• Examining the effects of host-glycan expression patterns in Group A streptococcal disease - David MP De Oliveira

• Are you Streptococcus suis? : Characterization of streptococcal strains from ruminants - Daisuke Takamatsu
• Human Streptococcus suis infections in South East Asia: Do we have molecular evidence for transboundary zoonotic infections? - Hoa T Ngo
• Type I interferon induced by Streptococcus suis serotype 2 is strain-dependent and may be beneficial for host survival - Marcelo Gottschalk
• Genomic changes in S. suis associated with clinical disease isolates - Eric L Miller
• Prediction of antimicrobial resistance phenotype from whole genome sequences in streptococcus suis - Nazreen F Hadjirin
• The prevalence and diversity of Streptococcus suis in the production and supply chain of pork in China and the UK   - Geng Zou

• Risk of acute rheumatic fever and acute post streptococcal glomerulonephritis following streptococcal infections of the throat and skin - Michael Baker
• Necrotizing fasciitis: overview with special regards to new perspectives - Olivier Chosidow
• A new fluorescent test system for the rapid detection of Group A streptococcus from throat swabs in a Point-of-Care setting - Andrea Ranzoni
• Clinical features of necrotizing soft tissue infections caused by beta-hemolytic Group A, C and G streptococci:  analysis of the Scandinavian INFECT study cohort - Steinar Skrede
• Community-based performance of a molecular test for streptococcal pharyngitis - Robert R Tanz
• Is the concept of rheumatogenic Group A Streptococcus a myth? A systematic literature review from 1944 to 2016 and a molecular analysis of the M-protein - Gabrielle J de Crombrugghe de Looringhe

• Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses - Thomas Proft
• Vaccine against S. pyogenes: where we are - Luiza Guilherme
• Constrained strain-specific immune induction underlies the epidemic of streptococcal pyoderma: overcoming immune resistance through vaccination - Manisha Pandey
• Development of an opsonophagocytic killing assay for group a streptococcus - Scott Jones
• In vitro and in vivo screening of potential vaccine candidates against prevalent Indian and Israel Streptococcus pyogenes serotypes - Pooja Sanduja
• Protocol for a group A streptococcal pharyngitis human challenge study - Joshua Osowicki

• Group B Streptococcus and the vaginal microbiome: dysbiosis, co-infection, and pathogenesis of Group B Streptococcus in pregnancy - Amanda Lewis
• Mechanisms of ascending Group B Streptococcus infection - Lakshmi Rajagopal
• Reduced incidence of neonatal early onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort. - Stellan Håkansson
• Group B Streptococcus biofilm regulatory protein A (brpA) contributes to host cell adherence and resistance to innate immune clearance - Katy Patras
• Evaluation of the Xpert^®GBS LB test (Cepheid) performed on antenatal screening LIM enrichment broth for detection of Streptococcus agalactiae or group B streptococcus (GBS) compared to the reference culture method. - Pierrette Melin
• Molecular basis of pathogenic Group B Streptococcus interactions with fungus Candida albicans - Grace R Pidwill

Noise curfew at 10:30pm on Denarau Island.